U.S. markets closed
  • S&P Futures

    3,314.25
    -19.50 (-0.58%)
     
  • Dow Futures

    27,247.00
    -161.00 (-0.59%)
     
  • Nasdaq Futures

    11,272.25
    -65.50 (-0.58%)
     
  • Russell 2000 Futures

    1,496.70
    -10.30 (-0.68%)
     
  • Crude Oil

    38.91
    -0.38 (-0.97%)
     
  • Gold

    1,895.20
    -8.00 (-0.42%)
     
  • Silver

    24.02
    -0.42 (-1.74%)
     
  • EUR/USD

    1.1734
    -0.0011 (-0.09%)
     
  • 10-Yr Bond

    0.6450
    -0.0180 (-2.71%)
     
  • Vix

    26.27
    +0.08 (+0.31%)
     
  • GBP/USD

    1.2840
    -0.0020 (-0.16%)
     
  • USD/JPY

    105.5990
    -0.0560 (-0.05%)
     
  • BTC-USD

    10,780.30
    -63.91 (-0.59%)
     
  • CMC Crypto 200

    230.96
    +1.29 (+0.56%)
     
  • FTSE 100

    5,897.50
    -30.43 (-0.51%)
     
  • Nikkei 225

    23,509.77
    -29.33 (-0.12%)
     

Citibank To Redeem $2.1 Billion In Notes This Month

support@smarteranalyst.com (Ben Mahaney)

Citigroup’s (C) consumer banking division Citibank on Friday announced that it will redeem $2.1 billion worth of 2.125% notes due October 20, 2020. Shares of the financial services company gained nearly 2% on Sept. 4.

Citibank has set Sept. 20 as the redemption date. The cash redemption price payable for the notes on Sept. 2 notes will equal par plus accrued and unpaid interest. Citibank stated, “The redemption announced is consistent with Citibank's liability management strategy, and reflects its ongoing efforts to enhance the efficiency of its funding and capital structure.” (See C stock analysis on TipRanks).

On July 20, Berenberg Bank analyst Eoin Mullany lifted Citigroup’s price target to $65 (23.8% upside potential) from $50 and reiterated a Buy rating. Mullany was impressed with the 2Q financial performance of US banks and stated that the investment banking revenues were “exceptionally strong” in the quarter.

Currently, the Street has a cautiously optimistic outlook on the stock. The Moderate Buy analyst consensus is based on 11 Buys, 2 Holds, and 1 Sell. The average price target of $72.20 implies upside potential of 37.5% to current levels. Shares are down by 34.3% year-to-date.

Related News:
Morgan Stanley Turns Bullish On Eli Lilly, Lifts PT
Truist Financial Lifts CrowdStrike’s PT On Strong 2Q Results
Market Crash Protection: 3 Defensive Stocks

More recent articles from Smarter Analyst: